Searched for
AUROBINDO PHARMA EUROPE BUSINESS
Europe can’t just air-condition its way out of the heatwave meltdownEurope's infrastructure, built for cold, is struggling with record heatwaves. From buckling train tracks and melting roads to hospitals can...- Empathy for Europe, 'mockery' for India? How the European heatwave exposes global double standards Indians face, Polish woman explainsA Polish woman living in India has gone viral after questioning what she called a double standard in how climate-related hardships are view...
- Over 95 million people in Europe face temperatures above 35°C TuesdayEurope is slowly recovering from its most severe heatwave ever, though over 95 million people will still endure 35C temperatures on Tuesday...
- GMR Airports among 7 stocks hit 52-week highs, rally up to 20% in a monthSeven BSE 200 stocks, led by GMR Airports and FSN E-Commerce Ventures, scaled fresh 52-week highs despite a weak broader market, gaining up...
- Built for cold, battered by heat, summer is bringing Europe to its kneesEurope is grappling with a devastating heatwave, claiming over 1,300 lives and straining medical facilities. The extreme temperatures highl...
- Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthThe Sensex fell 372 points on Monday, but nine BSE Midcap stocks touched fresh 52-week highs, signalling resilient investor confidence. Ban...
- Europe heatwave: Indian couple in Paris wait 90 minutes to buy a ‘luxury’ fan, say people are fighting to get oneEurope heatwave: An Indian couple in Paris waited 90 minutes to buy a fan as extreme temperatures hit Europe, disrupting transport, infrast...
- Europe is battling a record-breaking heatwave. What's making it so severe?Europe is grappling with unprecedented heat, shattering records across France, the UK, and several other nations. This deadly heatwave, arr...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Nifty has more room to run; stay selective: AnalystsIndian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommen...
- Why Europe is worried about 43°C when India sees over 48°C? Man asks about difference? Internet explainsA viral social media post questioning why Europe is alarmed by 43°C temperatures when parts of India regularly experience even higher heat ...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Europe heatwave: Where in Europe is the heatwave and when will it end? 101 million Europeans under 35°C+ due to "heat dome"Heatwave in Europe 2026: Europe is grappling with a severe heatwave, with over 100 million people experiencing temperatures above 35°C. Wes...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Federal Bank among 6 stocks that hit 52-week highs, rally up to 15% in a monthSix BSE200 stocks, including Federal Bank and Bharat Forge, hit fresh 52-week highs amid a strong market rally, reflecting bullish momentum...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
Load More
